Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains

Patrick Tremblay, Haydn L. Ball, Kiyotoshi Kaneko, Darlene Groth, Ramanujan S. Hegde, Fred E. Cohen, Stephen J. DeArmond, Stanley B. Prusiner, Jiri G. Safar

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Gerstmann-Sträussler-Scheinker (GSS) disease is a dominantly inherited, human prion disease caused by a mutation in the prion protein (PrP) gene. One mutation causing GSS is P102L, denoted P101L in mouse PrP (MoPrP). In a line of transgenic mice denoted Tg2866, the P101L mutation in MoPrP produced neurodegeneration when expressed at high levels. MoPrpSc(P101L) was detected both by the conformation-dependent immunoassay and after protease digestion at 4°C. Transmission of prions from the brains of Tg2866 mice to those of Tg196 mice expressing low levels of MoPrP(P101L) was accompanied by accumulation of protease-resistant MoPrpSc(P101L) that had previously escaped detection due to its low concentration. This conformer exhibited characteristics similar to those found in brain tissue from GSS patients. Earlier, we demonstrated that a synthetic peptide harboring the P101L mutation and folded into a β-rich conformation initiates GSS in Tg196 mice (29). Here we report that this peptide-induced disease can be serially passaged in Tg196 mice and that the PrP conformers accompanying disease progression are conformationally indistinguishable from MoPrpSc(P101L) found in Tg2866 mice developing spontaneous prion disease. In contrast to GSS prions, the 301V, RML, and 139A prion strains produced large amounts of protease-resistant PrPSc in the brains of Tg196 mice. Our results argue that MoPrpSc(P101L) may exist in at least several different conformations, each of which is biologically active. Such conformations occurred spontaneously in Tg2866 mice expressing high levels of MoPrP C(P101L) as well as in Tg196 mice expressing low levels of MoPrp C(P101L) that were inoculated with brain extracts from ill Tg2866 mice, with a synthetic peptide with the P101L mutation and folded into a β-rich structure, or with prions recovered from sheep with scrapie or cattle with bovine spongiform encephalopathy.

Original languageEnglish (US)
Pages (from-to)2088-2099
Number of pages12
JournalJournal of Virology
Volume78
Issue number4
DOIs
StatePublished - Feb 2004

Fingerprint

PrPSc proteins
Prions
synthetic peptides
prions
mutants
Peptides
mice
Mutation
Prion Diseases
Peptide Hydrolases
Brain
mutation
brain
proteinases
prion diseases
Bovine Spongiform Encephalopathy
Scrapie
Immunoassay
Transgenic Mice
Disease Progression

ASJC Scopus subject areas

  • Immunology

Cite this

Tremblay, P., Ball, H. L., Kaneko, K., Groth, D., Hegde, R. S., Cohen, F. E., ... Safar, J. G. (2004). Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains. Journal of Virology, 78(4), 2088-2099. https://doi.org/10.1128/JVI.78.4.2088-2099.2004

Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains. / Tremblay, Patrick; Ball, Haydn L.; Kaneko, Kiyotoshi; Groth, Darlene; Hegde, Ramanujan S.; Cohen, Fred E.; DeArmond, Stephen J.; Prusiner, Stanley B.; Safar, Jiri G.

In: Journal of Virology, Vol. 78, No. 4, 02.2004, p. 2088-2099.

Research output: Contribution to journalArticle

Tremblay, P, Ball, HL, Kaneko, K, Groth, D, Hegde, RS, Cohen, FE, DeArmond, SJ, Prusiner, SB & Safar, JG 2004, 'Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains', Journal of Virology, vol. 78, no. 4, pp. 2088-2099. https://doi.org/10.1128/JVI.78.4.2088-2099.2004
Tremblay, Patrick ; Ball, Haydn L. ; Kaneko, Kiyotoshi ; Groth, Darlene ; Hegde, Ramanujan S. ; Cohen, Fred E. ; DeArmond, Stephen J. ; Prusiner, Stanley B. ; Safar, Jiri G. / Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains. In: Journal of Virology. 2004 ; Vol. 78, No. 4. pp. 2088-2099.
@article{2a00898b63cd4a978163216590618252,
title = "Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains",
abstract = "Gerstmann-Str{\"a}ussler-Scheinker (GSS) disease is a dominantly inherited, human prion disease caused by a mutation in the prion protein (PrP) gene. One mutation causing GSS is P102L, denoted P101L in mouse PrP (MoPrP). In a line of transgenic mice denoted Tg2866, the P101L mutation in MoPrP produced neurodegeneration when expressed at high levels. MoPrpSc(P101L) was detected both by the conformation-dependent immunoassay and after protease digestion at 4°C. Transmission of prions from the brains of Tg2866 mice to those of Tg196 mice expressing low levels of MoPrP(P101L) was accompanied by accumulation of protease-resistant MoPrpSc(P101L) that had previously escaped detection due to its low concentration. This conformer exhibited characteristics similar to those found in brain tissue from GSS patients. Earlier, we demonstrated that a synthetic peptide harboring the P101L mutation and folded into a β-rich conformation initiates GSS in Tg196 mice (29). Here we report that this peptide-induced disease can be serially passaged in Tg196 mice and that the PrP conformers accompanying disease progression are conformationally indistinguishable from MoPrpSc(P101L) found in Tg2866 mice developing spontaneous prion disease. In contrast to GSS prions, the 301V, RML, and 139A prion strains produced large amounts of protease-resistant PrPSc in the brains of Tg196 mice. Our results argue that MoPrpSc(P101L) may exist in at least several different conformations, each of which is biologically active. Such conformations occurred spontaneously in Tg2866 mice expressing high levels of MoPrP C(P101L) as well as in Tg196 mice expressing low levels of MoPrp C(P101L) that were inoculated with brain extracts from ill Tg2866 mice, with a synthetic peptide with the P101L mutation and folded into a β-rich structure, or with prions recovered from sheep with scrapie or cattle with bovine spongiform encephalopathy.",
author = "Patrick Tremblay and Ball, {Haydn L.} and Kiyotoshi Kaneko and Darlene Groth and Hegde, {Ramanujan S.} and Cohen, {Fred E.} and DeArmond, {Stephen J.} and Prusiner, {Stanley B.} and Safar, {Jiri G.}",
year = "2004",
month = "2",
doi = "10.1128/JVI.78.4.2088-2099.2004",
language = "English (US)",
volume = "78",
pages = "2088--2099",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains

AU - Tremblay, Patrick

AU - Ball, Haydn L.

AU - Kaneko, Kiyotoshi

AU - Groth, Darlene

AU - Hegde, Ramanujan S.

AU - Cohen, Fred E.

AU - DeArmond, Stephen J.

AU - Prusiner, Stanley B.

AU - Safar, Jiri G.

PY - 2004/2

Y1 - 2004/2

N2 - Gerstmann-Sträussler-Scheinker (GSS) disease is a dominantly inherited, human prion disease caused by a mutation in the prion protein (PrP) gene. One mutation causing GSS is P102L, denoted P101L in mouse PrP (MoPrP). In a line of transgenic mice denoted Tg2866, the P101L mutation in MoPrP produced neurodegeneration when expressed at high levels. MoPrpSc(P101L) was detected both by the conformation-dependent immunoassay and after protease digestion at 4°C. Transmission of prions from the brains of Tg2866 mice to those of Tg196 mice expressing low levels of MoPrP(P101L) was accompanied by accumulation of protease-resistant MoPrpSc(P101L) that had previously escaped detection due to its low concentration. This conformer exhibited characteristics similar to those found in brain tissue from GSS patients. Earlier, we demonstrated that a synthetic peptide harboring the P101L mutation and folded into a β-rich conformation initiates GSS in Tg196 mice (29). Here we report that this peptide-induced disease can be serially passaged in Tg196 mice and that the PrP conformers accompanying disease progression are conformationally indistinguishable from MoPrpSc(P101L) found in Tg2866 mice developing spontaneous prion disease. In contrast to GSS prions, the 301V, RML, and 139A prion strains produced large amounts of protease-resistant PrPSc in the brains of Tg196 mice. Our results argue that MoPrpSc(P101L) may exist in at least several different conformations, each of which is biologically active. Such conformations occurred spontaneously in Tg2866 mice expressing high levels of MoPrP C(P101L) as well as in Tg196 mice expressing low levels of MoPrp C(P101L) that were inoculated with brain extracts from ill Tg2866 mice, with a synthetic peptide with the P101L mutation and folded into a β-rich structure, or with prions recovered from sheep with scrapie or cattle with bovine spongiform encephalopathy.

AB - Gerstmann-Sträussler-Scheinker (GSS) disease is a dominantly inherited, human prion disease caused by a mutation in the prion protein (PrP) gene. One mutation causing GSS is P102L, denoted P101L in mouse PrP (MoPrP). In a line of transgenic mice denoted Tg2866, the P101L mutation in MoPrP produced neurodegeneration when expressed at high levels. MoPrpSc(P101L) was detected both by the conformation-dependent immunoassay and after protease digestion at 4°C. Transmission of prions from the brains of Tg2866 mice to those of Tg196 mice expressing low levels of MoPrP(P101L) was accompanied by accumulation of protease-resistant MoPrpSc(P101L) that had previously escaped detection due to its low concentration. This conformer exhibited characteristics similar to those found in brain tissue from GSS patients. Earlier, we demonstrated that a synthetic peptide harboring the P101L mutation and folded into a β-rich conformation initiates GSS in Tg196 mice (29). Here we report that this peptide-induced disease can be serially passaged in Tg196 mice and that the PrP conformers accompanying disease progression are conformationally indistinguishable from MoPrpSc(P101L) found in Tg2866 mice developing spontaneous prion disease. In contrast to GSS prions, the 301V, RML, and 139A prion strains produced large amounts of protease-resistant PrPSc in the brains of Tg196 mice. Our results argue that MoPrpSc(P101L) may exist in at least several different conformations, each of which is biologically active. Such conformations occurred spontaneously in Tg2866 mice expressing high levels of MoPrP C(P101L) as well as in Tg196 mice expressing low levels of MoPrp C(P101L) that were inoculated with brain extracts from ill Tg2866 mice, with a synthetic peptide with the P101L mutation and folded into a β-rich structure, or with prions recovered from sheep with scrapie or cattle with bovine spongiform encephalopathy.

UR - http://www.scopus.com/inward/record.url?scp=0842304471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842304471&partnerID=8YFLogxK

U2 - 10.1128/JVI.78.4.2088-2099.2004

DO - 10.1128/JVI.78.4.2088-2099.2004

M3 - Article

VL - 78

SP - 2088

EP - 2099

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 4

ER -